20 articles
New research reveals how consuming adequate daily fiber through 'fibermaxxing' may reduce disease risk and improve long-term health outcomes.
Most Americans eat half the fiber needed for optimal gut health. Here's why prebiotic foods dramatically cut disease risk and death.
Major fitness chain deploys cordless metabolic testing masks across all locations, offering lab-grade VO2 max assessments during workouts.
Early data show sustained telomere lengthening in blood cells, while a new licensing deal advances a dystrophin therapy for Duchenne muscular dystrophy.
FORZINITY becomes the first FDA-approved therapy targeting mitochondria directly, launching for Barth syndrome patients amid a company rebrand.
Resolution Therapeutics is advancing engineered macrophage therapies using LNP-mRNA tech to treat liver disease, lung fibrosis, and more.
Life Time's SpiroFit brings lab-grade VO₂ max and metabolic testing to everyday gym-goers, turning a key longevity biomarker into actionable fitness data.
Elysium Health launches Creatine+, blending creatine, HMB, and pomegranate polyphenols to support strength, recovery, and healthy aging.
FGF21 extends lifespan in animals by 30-40%. Here's what exercise and diet research reveals about boosting it naturally.
RTX001, a regenerative macrophage cell therapy, reduced liver inflammation and fibrosis in mouse models ahead of Phase I/II trial results.
Dr Valter Longo argues the 5-day fasting-mimicking diet triggers deep cellular repair — from autophagy peaks to tissue regeneration after refeeding.
MetaShape's MS 001 showed muscle-sparing and enhanced fat burning in animal studies when combined with semaglutide — targeting GLP-1's key flaws.
A BET inhibitor called RVX-208 reprogrammed diseased perivascular fat, restoring blood vessel function in obese hypertensive patients.
Sironax's SARM1 inhibitor SIR2501 wins FDA Fast Track status for chemotherapy-induced nerve damage, with trials also targeting ALS.
A single FGF21 gene injection in aging mice extended median lifespan by 20%, reversing fat gain, inflammation, and organ decline.
A new biotech-pharma partnership aims to identify biological targets that could reverse liver fibrosis, not just slow it down.
New research shows vegetarian diets and specific plant compounds can heal intestinal barrier damage and reduce systemic inflammation.
Reducing protein to recommended levels may double the longevity hormone FGF21, improving fat loss and insulin sensitivity within weeks.
Research shows 8 prunes daily outperform medications and fiber supplements for constipation without side effects.
FibroBiologics begins a Phase 1/2 trial testing a fibroblast-spheroid cell therapy for diabetic foot ulcers in up to 120 patients.
